Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline ModelHeather Gray‐Edwards, Douglas R. Martin, Yvonne L. Latour et al.|Molecular Therapy|2017Cited by 58
Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosisYvonne L. Latour, Cynthia J. Tifft, Robin Yoon et al.|Molecular Genetics and Metabolism Reports|2019Cited by 58
MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosisDebra S. Regier, Cynthia J. Tifft, Hyuk‐Joon Kwon et al.|American Journal of Medical Genetics Part A|2015Cited by 41